Hormonal contraception and bone metabolism: A systematic review

Contraception

Volumn 86, Issue 6, 2012, Pages 606-621

  Nappi, Carmine ^a   Bifulco, Giuseppe ^a   Tommaselli, Giovanni A ^a   Gargano, Virginia ^a   Di Carlo, Costantino ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bone mineral density; Contraceptives; Fracture risk

Indexed keywords

CONTRACEPTIVE AGENT; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; OSTEOPROTEGERIN; PROGESTERONE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SEX HORMONE;

AGE DISTRIBUTION; BONE ATROPHY; BONE DEMINERALIZATION; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE REMODELING; CELL DIFFERENTIATION; CELL FUSION; CELL MIGRATION; CLIMACTERIUM; DISEASE COURSE; DOSE RESPONSE; FRACTURE; HORMONAL CONTRACEPTION; HORMONE RELEASE; HUMAN; INTERMETHOD COMPARISON; METABOLIC REGULATION; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VAGINA RING;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; ESTRADIOL CONGENERS; FEMALE; FRACTURES, BONE; HUMANS; OSTEOPOROTIC FRACTURES; PROGESTERONE CONGENERS; RISK; TRANSDERMAL PATCH;

EID: 84869087179     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.04.009     Document Type: Review

References (192)

1. G. Fabbri, F. Petraglia, and A. Segre Reduced spinal bone density in young women with amenorrhoea Eur J Obstet Gynecol Reprod Biol 41 1991 117 122
2. M.C. Davies, M.L. Hall, and H.S. Jacobs Bone mineral loss in young women with amenorrhea Br Med J 301 1990 790 793 (Pubitemid 20352579)
3. B.L. Drinkwater, B. Brummer, and C.H. Chesnut III Menstrual history as a determinant of current bone density in young athletes J Am Med Assoc 263 1990 545 548 (Pubitemid 20030262)
4. ESHRE Capri Workshop Group Female contraception over 40 Hum Reprod Update 15 2009 599 612
5. X. Feng, and J.M. McDonald Disorders of bone remodeling Annu Rev Pathol 6 2011 121 145
6. G.D. Roodman Advances in bone biology: the osteoclast Endocr Rev 17 1996 308 332 (Pubitemid 26277978)
7. W.J. Boyle, W.S. Simonet, and D.L. Lacey Osteoclast differentiation and activation Nature 423 2003 337 342 (Pubitemid 40852708)
8. A.L. Boskey Biomineralization: conflicts, challenges, and opportunities J Cell Biochem 30-31 Suppl. 1998 83 91 (Pubitemid 29028729)
9. J.C. Gallagher, and A.J. Sai Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis Maturitas 65 2010 301 307
10. H.K. Genant, C.E. Cann, B. Ettinger, and G.S. Gordan Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy Ann Intern Med 97 1982 699 705 (Pubitemid 13251641)
11. B.L. Riggs, S. Khosla, and L.J. Melton III Sex steroids and the construction and conservation of the adult skeleton Endocr Rev 23 2002 279 302 (Pubitemid 34651948)
12. F. Syed, and S. Khosla Mechanisms of sex steroid effects on bone Biochem Biophys Res Commun 328 2005 688 696 (Pubitemid 40214350)
13. V. Seifert-Klauss, and J.C. Prior Progesterone and bone: actions promoting bone health in women J Osteoporos 2010 2010 845180
14. E.F. Eriksen, D.S. Colvard, and N.J. Berg Evidence of estrogen receptors in normal human osteoblast-like cells Science 241 1988 84 86
15. B.S. Komm, C.M. Terpening, D.J. Benz, K.A. Graeme, B.W. O'Malley, and M.R. Haussler Estrogen binding receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells Science 241 1988 81 84
16. V.L. Davis, J.F. Couse, T.K. Gray, and K.S. Korach Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines J Bone Miner Res 9 1994 983 991 (Pubitemid 24191785)
17. M.J. Oursler, P. Osdoby, J. Pyfferoen, B.L. Riggs, and T.C. Spelsberg Avian osteoclasts as estrogen target cells Proc Natl Acad Sci U S A 88 1991 6613 6666
18. M.J. Oursler, L. Pederson, L. Fitzpatrick, and B.L. Riggs Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells Proc Natl Acad Sci U S A 91 1994 5227 5231 (Pubitemid 24174299)
19. I. Braidman, C. Baris, and L. Wood Preliminary evidence for impaired estrogen receptor-α protein expression in osteoblasts and osteocytes from men with idiopathic osteoporosis Bone 26 2000 423 427 (Pubitemid 30204461)
20. S. Bord, A. Horner, S. Beavan, and J. Compston Estrogen receptors α and ß are differentially expressed in developing human bone Endocrinology 86 2001 2309 2314 (Pubitemid 32472956)
21. F.P. Chen, K.C. Wang, and J.D. Huang Effect of estrogen on the activity and growth of human osteoclasts in vitro Taiwan J Obstet Gynecol 48 2009 350 355
22. M.J. Oursler, L. Pederson, J. Pyfferoen, P. Osdoby, L. Fitzpatrick, and T.C. Spelsberg Estrogen modulation of avian osteoclast lysosomal gene expression Endocrinology 132 1993 1373 1380 (Pubitemid 23068662)
23. H. Mano, T. Yuasa, and T. Kameda Mammalian mature osteoclasts as estrogen target cells Biochem Biophys Res Commun 223 1996 637 642 (Pubitemid 26246125)
24. N. Furuyama, and Y. Fujisawa Regulation of collagenolytic cysteine protease synthesis by estrogen in osteoclasts Steroids 65 2000 371 378 (Pubitemid 30427334)
25. V. Parikka, P. Lehenkari, and M.L. Sassi Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts Endocrinology 142 2001 5371 5378 (Pubitemid 33131970)
26. R.L. Jilka Cytokines, bone remodeling, and estrogen deficiency: a 1998 update Bone 23 1998 75 81 (Pubitemid 28379866)
27. G.B. Di Gregorio, M. Yamamoto, and A.A. Ali Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol J Clin Invest 107 2001 803 812 (Pubitemid 32274033)
28. S.A. Krum, G.A. Miranda-Carboni, and P.V. Hauschka Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival EMBO J 27 2008 535 545 (Pubitemid 351225684)
29. T. Kameda, H. Mano, and T. Yuasa Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts J Exp Med 186 1997 489 495 (Pubitemid 27360793)
30. T. Nakamura, Y. Imai, and T. Matsumoto Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts Cell 130 2007 811 823 (Pubitemid 47332572)
31. Y. Imai, M.Y. Youn, and S. Kondoh Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts Ann N Y Acad Sci 1173 Suppl. 1 2009 E31 E39
32. M.A. Anderson, E. Maraskovsky, and W.L. Billingsley A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic cell function Nature 390 1997 175 179 (Pubitemid 27507987)
33. H. Hsu, D.L. Lacey, and C.R. Dunstan Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand Proc Natl Acad Sci U S A 96 1999 3540 3545 (Pubitemid 29168945)
34. S. Khosla The OPG/RANKL/RANK system Endocrinology 142 2001 5050 5055
35. L.C. Hofbauer, S. Khosla, C.R. Dunstan, D.L. Lacey, T.C. Spelsberg, and B.L. Riggs Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells Endocrinology 140 1999 4367 4370 (Pubitemid 30647136)
36. C. Di Carlo, G.A. Tommaselli, and V. Gargano Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women Menopause 14 2007 38 44 (Pubitemid 46072005)
37. A.S. Turner Animal models of osteoporosis - necessity and limitations Eur Cell Mater 1 2001 66 81 (Pubitemid 38956756)
38. D.N. Kalu The ovariectomized rat model of postmenopausal bone loss Bone Miner 15 1991 175 191
39. N.E. Lane, D. Haupt, D.B. Kimmel, G. Modin, and J.H. Kinney Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat J Bone Miner Res 14 1999 206 214 (Pubitemid 29066245)
40. N.A. Sims, P. Clément-Lacroix, and D. Minet A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice J Clin Invest 111 2003 1319 1327 (Pubitemid 36554702)
41. S.C. Manolagas, and R.L. Jilka Bone marrow, cytokines, and bone remodeling - emerging insights into the pathophysiology of osteoporosis N Engl J Med 332 1995 305 311
42. R. Pacifici Cytokines, estrogen, and postmenopausal osteoporosis - the second decade Endocrinology 139 1998 2659 2661
43. S.C. Manolagas The role of IL-6 type cytokines and their receptors in bone Ann N Y Acad Sci 840 1998 194 204
44. S.C. Lin, T. Yamate, and Y. Taguchi Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow J Clin Invest 100 1997 1980 1990 (Pubitemid 27459351)
45. C. Miyaura, K. Kusano, and T. Masuzawa Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6 J Bone Miner Res 10 1995 1365 1373
46. T. Sunyer, J. Lewis, P. Collin-Osdoby, and P. Osdoby Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells J Clin Invest 103 1999 1409 1418 (Pubitemid 29535497)
47. S. Srivastava, M.N. Weitzmann, S. Cenci, F.P. Ross, S. Adler, and R. Pacifici Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD J Clin Invest 104 1999 503 513 (Pubitemid 29534334)
48. S. Srivastava, W.M. Neale, and R.B. Kimble Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of egr-1 and its interaction with Sp-1 J Clin Invest 102 1998 1850 1859 (Pubitemid 28533832)
49. M.J. Oursler, C. Cortese, and P.E. Keeting Modulation of transforming growth factor-ß production in normal human osteoblast-like cells by 17ß-estradiol and parathyroid hormone Endocrinology 129 1991 3313 3320
50. D.E. Hughes, A. Dai, J.C. Tiffee, H.H. Li, G.R. Mundy, and B.F. Boyce Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-ß Nat Med 2 1996 1132 1136
51. Y.Y. Kim, S.H. Kim, and S. Oh Increased fat due to estrogen deficiency induces bone loss by elevating monocyte chemoattractant protein-1 (MCP-1) production Mol Cells 29 2010 277 282
52. L.L. Wei, M.W. Leach, R.S. Miner, and L.M. Demers Evidence for progesterone receptors in human osteoblast-like cells Biochem Biophys Res Commun 195 1993 525 532 (Pubitemid 23280448)
53. P. Mac Namara, C. O'Shaughnessy, P. Manduca, and H.C. Loughrey Progesterone receptors are expressed in human osteoblast-like cell lines and in primary human osteoblast cultures Calcif Tissue Int 57 1995 436 441
54. P. Mac Namara, and H.C. Loughrey Progesterone receptor A and B isoform expression in human osteoblasts Calcif Tissue Int 63 1998 39 46 (Pubitemid 28289933)
55. J.M. Pensler, J.A. Radosevich, R. Higbee, and C.B. Langman Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors J Bone Miner Res 5 1990 797 802 (Pubitemid 20294763)
56. M.C. Slootweg, A.G. Ederveen, L.P. Schot, W.G. Schoonen, and H.J. Kloosterboer Oestrogen and progestogen synergistically stimulate human and rat osteoblast proliferation J Endocrinol 133 1992 R5 R8
57. J.C. Prior Progesterone as a bone-trophic hormone Endocr Rev 11 1990 386 398 (Pubitemid 20182875)
58. D.N. Kalu, E. Salerno, and C.C. Liu A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat Bone Miner 15 1991 109 123
59. E.I. Barengolts, P.V. Lathon, and F.G. Lindh Progesterone antagonist RU486 has bone-sparing effects in ovariectomized rats Bone 17 1995 21 25
60. D.J. Rickard, U.T. Iwaniec, and G. Evans Bone growth and turnover in progesterone receptor knockout mice Endocrinology 149 2008 2383 2390 (Pubitemid 351574494)
61. E.I. Barengolts, P.V. Lathon, and F.G. Lindh Progesterone antagonist RU 486 has bone-sparing effects in ovariectomized rats Bone 17 1995 21 25
62. T. Abe, J.W. Chow, J.M. Lean, and T.J. Chambers The progesterone antagonist, RU486, does not affect basal or estrogen-stimulated cancellous bone formation in the rat Bone Miner 19 1992 225 233
63. W. Yao, W. Dai, and M. Shahnazari Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice PLoS One 5 7 2010 e11410
64. Practice Committee of American Society for Reproductive Medicine Hormonal contraception: recent advances and controversies Fertil Steril 90 2008 S103 S113
65. S.L. Martins, K.M. Curtis, and A.F. Glasier Combined hormonal contraception and bone health: a systematic review Contraception 73 2006 445 469
66. L.M. Lopez, D.A. Grimes, K.F. Schulz, and K.M. Curtis Steroidal contraceptives: effect on bone fractures in women Cochrane Database Syst Rev 6 7 2011
67. WHO Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group World Health Organ Tech Rep Ser 843 1994 1 129
68. S.L. Hui, C.W. Slemenda, and C.C. Johnston Jr. Age and bone mass as predictors of fracture in a prospective study J Clin Invest 81 6 1988 1804 1809
69. P.D. Ross, R.D. Wasnich, and J.M. Vogel Detection of prefracture spinal osteoporosis using bone mineral absorptiometry J Bone Miner Res 3 1 1988 1 11
70. S.R. Cummings, D.M. Black, and M.C. Nevitt Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group JAMA 263 5 1990 665 668 (Pubitemid 20042530)
71. P. Gärdsell, O. Johnell, and B.E. Nilsson The predictive value of bone loss for fragility fractures in women: a longitudinal study over 15 years Calcif Tissue Int 49 1991 90 94
72. A.B. Berenson, C.M. Radecki, J.J. Grady, V.I. Rickert, and A. Thomas A prospective, controlled study of the effects of hormonal contraception on bone mineral density Obstet Gynecol 98 2001 576 582 (Pubitemid 32907449)
73. C. Nappi, A. Di Spiezio Sardo, and G. Acunzo Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study Contraception 67 2003 355 359 (Pubitemid 36556224)
74. C. Nappi, A. Di Spiezio Sardo, E. Greco, G.A. Tommaselli, E. Giordano, and M. Guida Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density Obstet Gynecol 105 2005 53 60 (Pubitemid 40189911)
75. J. Endrikat, E. Mih, and B. Dusterberg A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density Contraception 69 2004 179 187 (Pubitemid 38224215)
76. V. Gargano, M. Massaro, I. Morra, C. Formisano, C. Di Carlo, and C. Nappi Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study Contraception 78 2008 10 15
77. M. Hartard, C. Kleinmond, and P. Luppa Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles Contraception 74 2006 367 375 (Pubitemid 44550041)
78. A.M. Paoletti, M. Orru, and S. Floris Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women Contraception 61 2000 259 263 (Pubitemid 30427213)
79. C. Cooper, P. Hannaford, P. Croft, and C.R. Kay Oral contraceptive pill use and fractures in women: a prospective study Bone 14 1993 41 45 (Pubitemid 23081248)
80. M. Vessey, J. Mant, and R. Painter Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study Contraception 57 1998 231 235 (Pubitemid 28280910)
81. D. Barad, C. Kooperberg, J. Wactawsi-Wende, J. Liu, S. Hendrix, and N. Watts Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study Fertil Steril 84 2005 374 383 (Pubitemid 41125258)
82. C. La Vecchia, A. Tavani, and S. Gallus Oral contraceptives and risk of hip fractures Lancet 354 1999 335 336 (Pubitemid 29348756)
83. K. Michaelsson, J.A. Baron, B.Y. Farahmand, I. Persson, and S. Ljunghall Oral contraceptive use and risk of hip fracture: a case-control study Lancet 353 1999 1481 1484 (Pubitemid 29204366)
84. P. Vestergaard, L. Rejnmark, and L. Mosekilde Oral contraceptive use and risk of fractures Contraception 73 2006 571 576 (Pubitemid 43766216)
85. H. Mallmin, S. Ljunghall, I. Persson, and R. Bergström Risk factors for fractures of the distal forearm: a population-based case-control study Osteoporos Int 4 1994 298 304
86. T.W. O'Neill, D. Marsden, J.E. Adams, and A.J. Silman Risk factors, falls, and fracture of the distal forearm in Manchester, UK J Epidemiol Community Health 50 1996 288 292 (Pubitemid 26237084)
87. T.W. O'Neill, A.J. Silman, D.M. Naves, C. Cooper, J. Kanis, and D. Felsenberg Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. European Vertebral Osteoporosis Study Group Osteoporos Int 7 1997 72 78 (Pubitemid 27077791)
88. C. Johansson, and D. Mellstrom An earlier fracture as a risk factor for new fracture and its association with smoking and menopausal age in women Maturitas 24 1996 97 106 (Pubitemid 26180109)
89. A.B. Berenson, C.R. Breitkopf, J.J. Grady, V.I. Rickert, and A. Thomas Effects of hormonal contraception on bone mineral density after 24 months of use Obstet Gynecol 103 2004 899 906 (Pubitemid 40458990)
90. K.L. Cobb, J.L. Kelsey, S. Sidney, B. Ettinger, and C.E. Lewis Oral contraceptives and bone mineral density in white and black women in CARDIA. Coronary Risk Development in Young Adults Osteoporos Int 13 2002 893 900 (Pubitemid 35364791)
91. R.B. Mazess, and H.S. Barden Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth control pills Am J Clin Nutr 53 1991 132 142 (Pubitemid 21917621)
92. A.M. Paoletti, M. Orru, and S. Lello Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mcg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women Contraception 70 2004 293 298 (Pubitemid 39286764)
93. C. Castelo-Branco, M.J. Martinez de Osaba, F. Pons, and J.A. Vanrell Effects on bone mass of two oral contraceptives containing ethinylestradiol and cyproterone acetate or desogestrel: results of a 2-year follow-up Eur J Contracept Reprod Health Care 3 1998 79 84 (Pubitemid 128690532)
94. S.D. Reed, D. Scholes, A.Z. LaCroix, L.E. Ichikawa, W.E. Barlow, and S.M. Ott Longitudinal changes in bone density in relation to oral contraceptive use Contraception 68 2003 177 182 (Pubitemid 38367485)
95. S.L. Corson Oral contraceptives for the prevention of osteoporosis J Reprod Med 38 1993 1015 1020 (Pubitemid 24012094)
96. D. Kritz-Silverstein, and E. Barrett-Connor Bone mineral density in postmenopausal women as determined by prior oral contraceptive use Am J Public Health 83 1993 100 102 (Pubitemid 23019080)
97. B.A. Cromer Effects of hormonal contraceptives on bone mineral density Drug Saf 20 1999 213 222 (Pubitemid 29134896)
98. M. Kleerekoper, R.S. Brienza, L.R. Schultz, and C.C. Johnson Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group Arch Intern Med 151 1991 1971 1976
99. M. Gambacciani, P. Monteleone, M. Ciaponi, A. Sacco, and A.R. Genazzani Effects of oral contraceptives on bone mineral density Treat Endocrinol 3 2004 191 196 (Pubitemid 38724504)
100. S. Sultana, S. Choudhury, and S.A. Choudhury Effect of combined oral contraceptives on bone mineral density in pre and postmenopausal women Mymensingh Med J 11 2002 12 14
101. J.A. Pasco, M.A. Kotowicz, M.J. Henry, S. Panahi, E. Seeman, and G.C. Nicholson Oral contraceptives and bone mineral density: a population-based study Am J Obstet Gynecol 182 2000 265 269 (Pubitemid 30127333)
102. S. Wei, A. Venn, C. Ding, S. Foley, L. Laslett, and G. Jones The association between oral contraceptive use, bone mineral density and fractures in women aged 50-80 years Contraception 84 4 2011 357 362
103. P. Wanichsetakul, A. Kamudhamas, P. Watanaruangkovit, Y. Siripakarn, and P. Visutakul Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception Contraception 65 2002 407 410 (Pubitemid 34804542)
104. F. Allali, L. El Mansouri, and F. Abourazzak The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women BMC Womens Health 9 2009 31
105. A. Afghani, A.V. Abbott, and R.A. Wiswell Bone mineral density in Hispanic women: role of aerobic capacity, fat-free mass, and adiposity Int J Sports Med 25 2004 384 390 (Pubitemid 38916418)
106. C. Collins, K. Thomas, A. Harding, S. Cook, J. Turner, and J. Collins The effect of oral contraceptives on lumbar bone density in premenopausal women J La State Med Soc 140 1988 35 39
107. P. Garnero, E. Sornay-Rendu, and P.D. Delmas Decreased bone turnover in oral contraceptive users Bone 16 1995 499 503
108. N. Goldsmith, and J. Johnston Bone mineral: effects of oral contraceptives, pregnancy, and lactation J Bone Joint Surg 57-A 5 1975 657 668
109. M.L. Hall, J. Heavens, I.D. Cullum, and P.J. Ell The range of bone density in normal British women J Bone Joint Surg 63 1990 266 269 (Pubitemid 20144189)
110. M.A. Hansen Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women Osteoporos Int 4 1994 123 128 (Pubitemid 24163543)
111. M. Hartard, P. Bottermann, P. Bartenstein, D. Jeschke, and M. Schwaiger Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity Contraception 55 1997 87 90 (Pubitemid 27114531)
112. G.A. Hawker, S. Forsmo, and S.M. Cadarette Correlates of forearm bone mineral density in young Norwegian women: the Nord-Trondelag Health Study Am J Epidemiol 156 2002 418 427 (Pubitemid 34976980)
113. M.M. Hreshchyshyn, A. Hopkins, S. Zylstra, and M. Anbar Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities Am J Obstet Gynecol 159 1988 318 322
114. B. Kanders, R. Lindsay, and D. Dempster Determinants of bone mass in young healthy women C. Christiansen, C. Arnaud, B. Nordin, A. Parfitt, W. Peck, B. Riggs, Proceedings of the Copenhagen International Symposium on Osteoporosis, Copenhagen 1984 Department of Clinical Chemistry, Glostrup Hospital Denmark 37 39
115. K. Laitinen, M. Valimaki, and P. Keto Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finnish women Calcif Tissue Int 48 1991 224 231
116. T. Lloyd, J.R. Buchanan, G.R. Ursino, C. Myers, G. Woodward, and D.R. Halbert Long-term oral contraceptive use does not affect trabecular bone density Am J Obstet Gynecol 160 1989 402 404 (Pubitemid 19065384)
117. J. MacDougall, M.C. Davies, and C.E. Overton Bone density in a population of long term oral contraceptive pill users does not differ from that in menstruating women Br J Fam Plann 25 1999 96 100 (Pubitemid 29504796)
118. L.J. Melton III, S.C. Bryant, and H.W. Wahner Influence of breastfeeding and other reproductive factors on bone mass later in life Osteoporos Int 3 1993 76 83 (Pubitemid 23088900)
119. S. Murphy, K.T. Khaw, and J.E. Compston Lack of relationship between hip and spine bone mineral density and oral contraceptive use Eur J Clin Invest 23 1993 108 111 (Pubitemid 23056959)
120. M. Nelson, A.B. Mayer, O. Rutherford, and D. Jones Calcium intake, physical activity and bone mass in pre-menopausal women J Hum Nutr Diet 4 1991 171 178
121. S.M. Ott, D. Scholes, A.Z. LaCroix, L.E. Ichikawa, C.K. Yoshida, and W.E. Barlow Effects of contraceptive use on bone biochemical markers in young women J Clin Endocrinol Metab 86 2001 179 185 (Pubitemid 32109794)
122. M. Perrotti, L. Bahamondes, C. Petta, and S. Castro Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate Fertil Steril 76 2001 469 473
123. D.B. Petitti, G. Piaggio, S. Mehta, M.C. Cravioto, and O. Meirik Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health Obstet Gynecol 95 2000 736 744 (Pubitemid 30210062)
124. D. Picard, L.G. Ste-Marie, and D. Coutu Premenopausal bone mineral content relates to height, weight and calcium intake during early adulthood Bone Miner 4 1988 299 309
125. J.C. Prior, S.A. Kirkland, and L. Joseph Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study CMAJ 165 2001 1023 1029 (Pubitemid 32964864)
126. A. Rodin, M. Chapman, and I. Fogelman Bone density in users of combined oral contraception. Preliminary reports of a pilot study Br J Fam Plann 16 1991 125 129
127. M.F. Sowers, R.B. Wallace, and J.H. Lemke Correlates of forearm bone mass among women during maximal bone mineralization Prev Med 14 1985 585 596 (Pubitemid 16191238)
128. J.C. Stevenson, B. Lees, M. Devenport, M.P. Cust, and K.F. Ganger Determinants of bone density in normal women: risk factors for future osteoporosis? Br Med J (Clin Res Ed) 298 1989 924 928 (Pubitemid 19104250)
129. W. Tharnprisarn, and S. Taneepanichskul Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women Contraception 66 2002 101 103 (Pubitemid 35245540)
130. C.M. Ulrich, C.C. Georgiou, C.M. Snow-Harter, and D.E. Gillis Bone mineral density in mother-daughter pairs: relations to lifetime exercise, lifetime milk consumption, and calcium supplements Am J Clin Nutr 63 1996 72 79 (Pubitemid 26005729)
131. L.S. Wallace, and J.E. Ballard Lifetime physical activity and calcium intake related to bone density in young women J Womens Health Gend Based Med 11 2002 389 398
132. The ESHRE Capri Workshop Group Noncontraceptive health benefits of combined oral contraception Hum Reprod Update 11 2005 513 525
133. M. Hartard, C. Kleinmond, M. Wiseman, E.R. Weissenbacher, D. Felsenberg, and R.G. Erben Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women Bone 40 2007 444 450 (Pubitemid 46075201)
134. F. Polatti, F. Perotti, N. Filippa, D. Gallina, and R.E. Nappi Bone mass and long-term monophasic oral contraceptive treatment in young women Contraception 51 1995 221 224
135. T.C. Register, M.J. Jayo, and C.P. Jerome Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys Osteoporos Int 7 1997 348 353 (Pubitemid 27346416)
136. B.A. Cromer Bone mineral density in adolescent and young adult women on injectable or oral contraception Curr Opin Obstet Gynecol 15 2003 353 357 (Pubitemid 37330378)
137. T. Lloyd, D.S. Taylor, M.H. Lin, A.E. Matthews, D.F. Eggli, and R.S. Legro Oral contraceptive use by teenage women does not affect peak bone mass: a longitudinal study Fertil Steril 74 2000 734 738
138. M. Lattakova, M. Borovsky, J. Payer, and Z. Killinger Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls Eur J Contracept Reprod Health Care 14 2009 207 214
139. H. Agostino, and G.J. Di Meglio Low-dose oral contraceptives in adolescents: how low can you go? Pediatr Adolesc Gynecol 23 2010 195 201
140. B.A. Cromer, J.M. Blair, and J.D. Mahan A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives J Pediatr 129 1996 671 676 (Pubitemid 27498275)
141. E. Lara-Torre, C.P. Edwards, S. Perlman, and S.P. Hertweck Bone mineral density in adolescent females using depot medroxyprogesterone acetate J Pediatr Adolesc Gynecol 17 2004 17 21 (Pubitemid 38315009)
142. M.E. Beksinska, I. Kleinschmidt, J.A. Smit, and T.M. Farley Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception Contraception 75 2007 438 443 (Pubitemid 46766652)
143. B.A. Cromer, M. Stager, and A. Bonny Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls J Adolesc Health 35 2004 434 441 (Pubitemid 39576013)
144. E. Rome, J. Ziegler, and M. Secic Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive J Pediatr Adolesc Gynecol 17 2004 373 377 (Pubitemid 39643071)
145. B.A. Cromer, A.E. Bonny, and M. Stager Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study Fertil Steril 90 2008 2060 2067
146. M.E. Beksinska, I. Kleinschmidt, J.A. Smit, T.M. Farley, and H.V. Rees Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception Contraception 80 2009 128 132
147. D. Scholes, L. Ichikawa, and A.Z. La Croix Oral contraceptive use and bone density in adolescent and young adult women Contraception 81 2010 35 40
148. WHO Medical eligibility criteria for contraceptive use 4th ed. 2009
149. M. Gambacciani, M. Ciaponi, B. Cappagli, C. Benussi, and A.R. Genazzani Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism Osteoporos Int 11 2000 544 548
150. M. Gambacciani, B. Cappagli, M. Ciaponi, C. Benussi, and A.R. Genazzani Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics Menopause 6 1999 43 48 (Pubitemid 29131758)
151. M. Gambacciani, A. Spinetti, F. Taponeco, B. Cappagli, L. Piaggesi, and P. Fioretti Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism Obstet Gynecol 83 1994 392 396 (Pubitemid 24067808)
152. M. Gambacciani, A. Spinetti, and B. Cappagli Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism Maturitas 19 1994 125 131 (Pubitemid 24268209)
153. A. Volpe, A. Amram, A. Cagnacci, and C. Battaglia Biochemical aspects of hormonal contraception: effects on bone metabolism Eur J Contracept Reprod Health Care 2 1997 123 126 (Pubitemid 127498172)
154. A.A. Shargil Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study Int J Fertil 30 1985 15 28 (Pubitemid 16216932)
155. J.A. Fortney, P.J. Feldblum, R.V. Talmage, J. Zhang, and S.E. Godwin Bone mineral density and history of oral contraceptive use J Reprod Med 39 1994 105
156. M. Tuppurainen, H. Kroger, S. Saarikoski, R. Honkanen, and E. Alhava The effect of previous oral contraceptive use on bone mineral density in perimenopausal women Osteoporos Int 4 1994 93 98 (Pubitemid 24103702)
157. M. Beksinska, J. Smit, I. Kleinschmidt, T. Farley, and F. Mbatha Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception Contraception 71 2005 170 175 (Pubitemid 40250197)
158. O. Johnell, and B.E. Nilsson Life-style and bone mineral mass in perimenopausal women Calcif Tissue Int 36 1984 354 356 (Pubitemid 14003824)
159. P. Masaryk, M. Lunt, and L. Benevolenskaya Effects of menstrual history and use of medications on bone mineral density: the EVOS study Calcif Tissue Int 63 1998 271 276 (Pubitemid 28443407)
160. N. Taechakraichana, K. Limpaphayom, T. Ninlagarn, K. Panyakhamlerd, S. Chaikittisilpa, and N. Dusitsin A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women Obstet Gynecol 95 2000 87 94 (Pubitemid 30001636)
161. M.J. Grainge, C.A.C. Coupland, S.J. Cliffe, C.E.D. Chilvers, and D.J. Hosking Reproductive, menstrual and menopausal factors: which are associated with bone mineral density in early postmenopausal women? Osteoporos Int 12 2001 777 787 (Pubitemid 32954636)
162. H. Enzelsberger, M. Metka, G. Heytmanek, B. Schurz, C. Kurz, and M. Kusztrich Influence of oral contraceptive use on bone density in climacteric women Maturitas 9 1988 375 378
163. W. Kuohung, L. Borgatta, and P. Stubblefield Low-dose oral contraceptives and bone mineral density: an evidence-based analysis Contraception 61 2000 77 82 (Pubitemid 30236327)
164. M. Gambacciani, B. Cappagli, V. Lazzarini, M. Ciaponi, F. Fruzzetti, and A.R. Genazzani Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density Maturitas 54 2006 176 180
165. P. Albertazzi, M. Bottazzi, and S.A. Steel Bone mineral density and depot medroxyprogesterone acetate Contraception 73 2006 577 583 (Pubitemid 43786283)
166. M.K. Clark, M.R. Sowers, S. Nichols, and B. Levy Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate Fertil Steril 82 2004 1580 1586 (Pubitemid 39611386)
167. K.M. Curtis, and S.L. Martins Progestogen-only contraception and bone density: a systematic review Contraception 73 2006 470 487
168. T. Cundy, J. Cornish, H. Roberts, H. Elder, and I.R. Reid Spinal bone density in women using depot medroxyprogesterone contraception Obstet Gynecol 92 1998 569 573 (Pubitemid 28449603)
169. T. Cundy, M. Evans, H. Roberts, D. Wattie, R. Ames, and I.R. Reid Bone density in women receiving depot medroxyprogesterone acetate for contraception BMJ 303 1991 13 16
170. A.M. Kaunitz, P.D. Miller, V.M. Rice, D. Ross, and M.R. McClung Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation Contraception 74 2006 90 99 (Pubitemid 44096901)
171. A.S. Viola, S. Castro, M.V. Bahamondes, A. Fernandes, C.F. Viola, and L. Bahamondes A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate Contraception 84 5 2011 e31 e37
172. D. Scholes, A.Z. LaCroix, S.M. Ott, L.E. Ichikawa, and W.E. Barlow Bone mineral density in women using depot medroxyprogesterone acetate for contraception Obstet Gynecol 93 1999 233 238 (Pubitemid 29068099)
173. Z. Harel, C.C. Johnson, and M.A. Gold Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections Contraception 81 2010 281 291
174. T. Cundy, J. Cornish, M.C. Evans, H. Roberts, and I.R. Reid Recovery of bone density in women who stop using medroxyprogesterone acetate BMJ 308 1994 247 248 (Pubitemid 24089097)
175. B.J. Orr-Walker, M.C. Evans, R.W. Ames, J.M. Clearwater, T. Cundy, and I.R. Reid The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal postmenopausal women Clin Endocrinol (Oxf) 49 1998 615 618 (Pubitemid 28529760)
176. D. Scholes, A.Z. LaCroix, L.E. Ichikawa, W.E. Barlow, and S.M. Ott Injectable hormone contraception and bone density: results from a prospective study Epidemiology 13 2002 581 587
177. L. Gai, J. Zhang, H. Zhang, P. Gai, L. Zhou, and Y. Liu The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age Contraception 83 2011 218 222
178. A.S. Viola, S. Castro, N.M. Marchi, M.V. Bahamondes, C.F. Viola, and L. Bahamondes Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate Contraception 84 2 2011 122 127
179. C. Meier, Y.B. Brauchli, S.S. Jick, M.E. Kraenzlin, and C.R. Meier Use of depot medroxyprogesterone acetate and fracture risk J Clin Endocrinol Metab 95 2010 4909 4916
180. T. Naessen, S.E. Olsson, and J. Gudmundson Differential effects on bone density of progestogen-only methods for contraception in premenopausal women Contraception 52 1995 35 39
181. S. Taneepanichskul, S. Intaraprasert, U. Theppisai, and K. Chaturachinda Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women Contraception 56 1997 153 155 (Pubitemid 27450825)
182. S. Intaraprasert, S. Taneepanichskul, U. Theppisai, and K. Chaturachinda Bone density in women receiving Norplant implants for contraception J Med Assoc Thai 80 1997 738 741 (Pubitemid 28067050)
183. L. Bahamondes, C. Monteiro-Dantas, and X. Espejo-Arce A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel- releasing contraceptive implants Hum Reprod 21 2006 466 470 (Pubitemid 43159924)
184. K.R. Meckstroth, and P.D. Darney Implant contraception Semin Reprod Med 19 2001 339 354 (Pubitemid 34028422)
185. M. Horowitz, J.M. Wishart, A.G. Need, H.A. Morris, and B.E. Nordin Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis Clin Endocrinol (Oxf) 39 1993 649 655 (Pubitemid 24010953)
186. R. Beerthuizen, A. van Beek, R. Massai, L. Mäkäräinen, J. Hout, and H.C. Bennink Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception Hum Reprod 15 2000 118 122 (Pubitemid 30035110)
187. S. Pongsatha, M. Ekmahachai, N. Suntornlimsiri, N. Morakote, and S. Chaovisitsaree Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2 years Int J Gynaecol Obstet 109 2010 223 225
188. WHO statement on hormonal contraception and bone health Wkly Epidemiol Rec 2005
189. M.V. Bahamondes, I. Monteiro, S. Castro, X. Espejo-Arce, and L. Bahamondes Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system Hum Reprod 25 2010 1158 1164
190. M. Massaro, C. Di Carlo, V. Gargano, C. Formisano, G. Bifulco, and C. Nappi Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study Contraception 81 2010 209 214
191. R. Massai, L. Mäkäräinen, A. Kuukankorpi, C. Klipping, I. Duijkers, and T. Dieben The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women Hum Reprod 20 2005 2764 2768 (Pubitemid 41487631)
192. Z. Harel, S. Riggs, R. Vaz, P. Flanagan, D. Harel, and J.T.J. Machan Bone accretion in adolescents using the combined estrogen and progestin transdermal contraceptive method Ortho Evra: a pilot study Pediatr Adolesc Gynecol 23 1 2010 23 31